These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
411 related articles for article (PubMed ID: 11144921)
1. Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis. Batheja N; Suriawinata A; Saxena R; Ionescu G; Schwartz M; Thung SN Mod Pathol; 2000 Dec; 13(12):1265-8. PubMed ID: 11144921 [TBL] [Abstract][Full Text] [Related]
2. Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma. Ahrendt SA; Eisenberger CF; Yip L; Rashid A; Chow JT; Pitt HA; Sidransky D J Surg Res; 1999 Jun; 84(1):88-93. PubMed ID: 10334895 [TBL] [Abstract][Full Text] [Related]
3. Utility of bile duct brushings for the early detection of cholangiocarcinoma in patients with primary sclerosing cholangitis. Moff SL; Clark DP; Maitra A; Pandey A; Thuluvath PJ J Clin Gastroenterol; 2006 Apr; 40(4):336-41. PubMed ID: 16633106 [TBL] [Abstract][Full Text] [Related]
4. [Result of p53, ki-67 protein expression in cholangiocarcinoma with in situ hybridization and immunohistochemistry methods]. Wang X; Zhang J; Chen J Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):57-60. PubMed ID: 12903495 [TBL] [Abstract][Full Text] [Related]
5. Bile duct expression of pancreatic and duodenal homeobox 1 in perihilar cholangiocarcinogenesis. Igarashi S; Matsubara T; Harada K; Ikeda H; Sato Y; Sasaki M; Matsui O; Nakanuma Y Histopathology; 2012 Aug; 61(2):266-76. PubMed ID: 22594685 [TBL] [Abstract][Full Text] [Related]
6. Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis. Adams DH; Hubscher SG; Shaw J; Johnson GD; Babbs C; Rothlein R; Neuberger JM Hepatology; 1991 Sep; 14(3):426-31. PubMed ID: 1714872 [TBL] [Abstract][Full Text] [Related]
7. Primary sclerosing cholangitis as a cause of false positive bile duct brushing cytology: report of two cases. Layfield LJ; Cramer H Diagn Cytopathol; 2005 Feb; 32(2):119-24. PubMed ID: 15637668 [TBL] [Abstract][Full Text] [Related]
8. p53 Protein overexpression in cholangiocarcinoma arising in primary sclerosing cholangitis. Rizzi PM; Ryder SD; Portmann B; Ramage JK; Naoumov NV; Williams R Gut; 1996 Feb; 38(2):265-8. PubMed ID: 8801209 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis. Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890 [TBL] [Abstract][Full Text] [Related]
10. Two distinct pathways of carcinogenesis in primary sclerosing cholangitis. Zen Y; Quaglia A; Heaton N; Rela M; Portmann B Histopathology; 2011 Dec; 59(6):1100-10. PubMed ID: 22175890 [TBL] [Abstract][Full Text] [Related]
12. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Tischendorf JJ; Krüger M; Trautwein C; Duckstein N; Schneider A; Manns MP; Meier PN Endoscopy; 2006 Jul; 38(7):665-9. PubMed ID: 16673310 [TBL] [Abstract][Full Text] [Related]
13. Anti-p53 antibodies and p53 protein expression in cholangiocarcinoma. Limpaiboon T; Sripa B; Wongkham S; Bhudhisawasdi V; Chau-in S; Teerajetgul Y Hepatogastroenterology; 2004; 51(55):25-8. PubMed ID: 15011824 [TBL] [Abstract][Full Text] [Related]
14. Spindle cell carcinoma of the intrahepatic bile duct in a patient with primary sclerosing cholangitis. Shinoda M; Shimazu M; Mukai M; Tanabe M; Hashiguchi N; Oda M; Kitajima M J Gastroenterol; 2003; 38(11):1091-6. PubMed ID: 14673729 [TBL] [Abstract][Full Text] [Related]
15. Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm. Nakanishi Y; Zen Y; Kondo S; Itoh T; Itatsu K; Nakanuma Y Hum Pathol; 2008 Aug; 39(8):1153-61. PubMed ID: 18495210 [TBL] [Abstract][Full Text] [Related]
16. An animal model of benign bile-duct stricture, sclerosing cholangitis and cholangiocarcinoma and the role of epidermal growth factor receptor in ductal proliferation. Cheifetz RE; Davis NL; Owen DA Can J Surg; 1996 Jun; 39(3):193-7. PubMed ID: 8640617 [TBL] [Abstract][Full Text] [Related]
17. The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acid. Rudolph G; Kloeters-Plachky P; Rost D; Stiehl A Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):487-91. PubMed ID: 17489059 [TBL] [Abstract][Full Text] [Related]
18. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'. Kozaka K; Sasaki M; Fujii T; Harada K; Zen Y; Sato Y; Sawada S; Minato H; Matsui O; Nakanuma Y Histopathology; 2007 Sep; 51(3):390-400. PubMed ID: 17553067 [TBL] [Abstract][Full Text] [Related]
19. Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis. Bergquist A; Broomé U Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):643-56. PubMed ID: 11492973 [TBL] [Abstract][Full Text] [Related]
20. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis. Jesudian AB; Jacobson IM Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]